- Life Sciences - 10:00 Predicting people’s ’brain age’ could help to spot who is at risk of early death
- Medicine - 10:00 Six ways Imperial researchers are working to eliminate malaria
- Business - 08:00 Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
- Social Sciences - Apr 24 Prenatal screening for Down’s syndrome seen as ‘routine practice’
- Medicine - Apr 24 Family caregivers help with wider range of healthcare tasks than thought
- Medicine - Apr 24 Electrical engineer puts sweat tech to the test
- Medicine - Apr 24 Yale‘s Dr. Patrick O’Connor partners with experts to address TV portrayals of addiction
- Medicine - Apr 24 Tiny ‘cages’ to keep vaccine supplies safe
- Medicine - Apr 24 Novartis real- world data at AAN confirms benefit of Gilenya on four key measures of disease activity in relapsing MS
- Medicine - Apr 24 Novartis expands global collaboration with Amgen to commercialize first-in- class AMG 334 (erenumab) program in migraine prevention in the US and Canada
- Medicine - Apr 24 ’In the Moment’ at TEDxStanford
- Medicine - Apr 24 Ideas sought for long- range planning process
- Environment - Apr 21 Earth day: Imperial event brings together experts to tackle air pollution
- Medicine - Apr 21 Yale experts offer thoughts on ‘Science Under Siege’
- Life Sciences - Apr 21 NIH Awards Team $7 Million for Autism Genetics Research
- Medicine - Apr 21 Senior salsa brings home the power of staying active
International health experts call for a special UN session on mental health
Professor Harry Minas, Director of the Centre for International Mental Health at the University of Melbourne has joined experts from the US and the UK to call for a United Nations General Assembly Special Session (UNGASS) on the topic.
Professor Minas said mental, neurological and substance abuse disorders were a core development issue requiring commitments to improve access to care, promote human rights and strengthen the evidence on effective prevention and treatment.
"The time has come for recognition at the highest levels of global development, namely the UN General Assembly, of the urgent need for a global strategy to address the global burden of MNS disorders," he said.
Mental, neurological, and substance use disorders (MNS disorders - a relatively new acronym
coined by the World Health Organization to refer to the complete range of disorders of the brain
and the mind) are leading contributors to the global burden of disease and profoundly impact the
social and economic well-being of individuals and communities.
Yet the majority of people affected by MNS disorders globally do not have access to evidence-based interventions and many experience discrimination and abuses of their human rights.
The authors outline three broad areas of action needing urgent investment: to enhance access to evidence-based packages of care for the treatment of MNS disorders; to realise the human rights commitment enshrined in the Convention on the Rights of Persons with Disabilities to ensure that people with MNS disorders live a life with dignity; and to expand knowledge about MNS disorders.
Professor Minas who is also the Secretariat, Movement for Global Mental Health, said securing the commitment of a majority of governments for a UNGASS would require a concerted effort from the diverse group of stakeholders concerned with MNS disorders.
"The fact that MNS disorders affect people in all countries should offer considerable incentive for investments by both public and private sectors in this initiative," he said.
The authors also encourage support for the development of a ’’People’s Charter for Mental Health’’ that will identify priority needs into practical actionable steps for implementation.
The authors conclude: "Together, this grand coalition of local, national, and global actors will converge their energies towards the implementation of a UNGASS to achieve the ultimate goal of reducing the global burden of MNS disorders."
Professor Minas is available for.
Last job offers
- Medicine/Pharmacology - 18.4
Professeur-e ordinaire ou associé-e, médecin-chef-fe du service de médecine interne de réhabilitation...
- Medicine/Pharmacology - 15.4
Chargé-e de cours à 40% dans le domaine neuro-musculaire
- Medicine/Pharmacology - 21.3
Dozentin / Dozenten für Pharmakologie und Pharmatechnologie mit Fachgruppenleitung
- Medicine/Pharmacology - 15.3
Professeur-e ordinaire ou associé-e, médecin adjoint-e agrégé-e
- Life Sciences - 24.4
Lecturer, Microbiology, School of Science and Health
- Medicine/Pharmacology - 24.4
899615 Clinical Professor of Cardiology
- Pedagogy/Education Science - 21.4
Professur (W2) auf Zeit (6 Jahre / tenure track) für Kinderchirurgie - translationale Forschung
- Medicine/Pharmacology - 21.4
Professur (W2) auf Zeit (6 Jahre / tenure track) für Kardiovaskulären Metabolismus